ABA. A. Bykhovsky

A. A. Bykhovsky

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. A. Bykhovsky has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Radiation Therapy Complications in Choroidal Melanoma and Strategies for Their Management

    by E. M. Svistunova, I. A. Al-Mousa, L. A. Insarkina, A. A. Bykhovsky, I. E. Panova

    Introduction . Organ-preserving modalities are the current standard of care in the management of choroidal melanoma (CM), with radiation therapy playing a pivotal role. Despite its high efficacy, radiation exposure is associated with a broad spectrum of post-radiation complications, which may compromise treatment outcomes and, in some cases, necessitate secondary enucleation. The objective of the work is to summarize current evidence on the use of radiation therapy in CM, analyze the range and incidence of post-radiation complications, identify associated risk factors, and evaluate strategies for prevention and management depending on the treatment modality. Materials and methods . A literature search and analysis of scientific publications in Russian and English was conducted using relevant keywords. Inclusion criteria: original studies (randomized and non-randomized clinical trials), reviews (meta-analyses and systematic reviews) relevant to the topic. Results and discussion . This review encompasses modern methods of radiation therapy for CM, including brachytherapy, proton beam therapy, and stereotactic radiosurgery, with attention to their indications and clinical efficacy. The types, frequency, and specific features of post-radiation complications are analyzed, including damage to the eyelid and periocular skin, cornea, lens, macula, optic nerve, secondary glaucoma, among others. Risk factors for such complications are discussed, along with available preventive and therapeutic approaches. Conclusion . Although different radiation modalities for CM share a similar spectrum of complications, their frequency and predominance vary considerably depending on the chosen technique. Most complications are manageable; however, neovascular glaucoma, scleromalacia, and persistent trophic corneal ulcers may require secondary enucleation. These outcomes highlight the need for improved prevention, early detection of complications, and clear patient selection criteria for organ-preserving treatment of choroidal melanoma.

  • Open Access

    OCT Biomarkers in Diagnostic of Uveitic and Radiation-induced Macular Edema

    by I. E. Panova, V. G. Gvazava, A. A. Bykhovsky, T. G. Zakaraiia

    Objective: tо evaluate characteristic OCT biomarkers of onset and recurrent uveitic and radiation-induced macular edema (ME) and determine their significance in assessing best corrected visual acuity (BCVA).Patients and methods. 48 patients (56 eyes) with radiation-induced (24 eyes) and uveitic (32 eyes) ME were enrolled in the study. All patients underwent OCT on Optovue RTVue XR Avanti. The following biomarkers were assessed to evaluate OCT morphostructural characteristics: foveal eversion, subretinal detachment, hyperreflective foci, ellipsoid zone disruption, disorganization of retinal inner layers (DRIL), and epiretinal membrane. Central retinal thickness was measured to analyze OCT morphometric characteristics.Results. There was no statistically significant difference in OCT biomarkers between uveitic and radiation-induced ME except for epiretinal membrane — this OCT biomarker was more common in radiation ME (p = 0.041). The presence of hyperreflective foci, ellipsoid zone disruption and DRIL in radiation-induced and uveitic ME were associated with lower BCVA (p < 0.001). The presence of subretinal detachment was characteristic for the onset ME (p = 0.002), while recurrent ME associated with a greater central retinal thickness, ellipsoid zone disruption (p = 0.029) and DRIL (p = 0.036).Conclusion. Radiation-induced and uveitic ME do not differ significantly in their OCT morphostructural characteristics and central retinal thickness. The recurrent course of radiation-induced and uveitic ME is characterized by the presence of ellipsoid zone disruption and DRIL, as well as greater central retinal thickness. Ellipsoid zone disruption, DRIL, and hyperreflective foci associated with lower BCVA in patients with uveitic and radiation-induced ME.

  • Open Access

    Hybrid Photodynamic Therapy as a Component of Combined Treatment of Uveal Melanoma (Preliminary Results)

    by E. V. Boiko, E. V. Samkovich, I. E. Panova, E. M. Svistunova, A. A. Ivanov, A. A. Bikhovsky

    Objective. To develop a technique of hybrid photodynamic therapy (PDT) and present its preliminary results in combined organ-preserving treatment of uveal melanoma (UM).Materials and methods. 4 patients with UM (T2aN0M0 — 2 patients, T3aN0M0 — 2 patients) were treated by hybrid PDT followed by Ru-106 + Rh-106 brachytherapy (BT). The initial UM prominence ranged from 7 to 8.6 mm (7.92 ± 0.67 mm), and the tumor base diameter ranged from 10.3 to 14 mm (12.10 ± 1.89 mm). PDT was performed using a chlorine photosensitizer at a rate of 1.0 mg/kg weight using a new hybrid technology, which consists of transpupillary and transscleral exposure to the tumor in one treatment session. Ru-106 + Rh-106 BT was performed according to the standard technique for up to 1 month after PDT.Results. The combined approach contributed to rapid rates of tumor regression at the early terms of dynamic follow-up and achievement of complete regression at the period of 12 months in 2 cases with initially “large” UM sizes. Decrease in the signs of intratumoral vascularization of UM was noted from the first month of follow-up and this tendency was maintained throughout the whole period.Conclusions. The presented preliminary results of hybrid PDT in combined treatment of UM expand the possibilities of organ-preserving treatment of largesized tumors due to direct cytotoxic and antiangiogenic effects on tumor substrate, as well as potentiation of radiation therapy.


  • Open Access

    Glucocorticosteroids and Postradiation Macular Edema: Rationale for Choice of Therapy and Efficacy of Use

    by I. E. Panova, A. A. Bikhovsky, E. V. Samkovich, E. M. Svistunova

    Purpose. To substantiate and study the effectiveness of intravitreal injection of dexamethasone implant (“Ozurdex”) based on OCT study of morphostructural biomarkers of post-radiation macular edema (PMO) in different terms of its detection.Patients and methods. 28 patients with PMO after Ru-106 ± Rh-106 (BT) brachytherapy for choroidal melanoma (CM). Study group (IG 1) — 18 patients with PMO detected up to 9 months after BT, IG 2 — 10 patients with PMO detected 9 months or more after BT. OCT parameters studied: height of foveolar and parafoveolar zones, presence of neuroepithelium detachment, disorganization of inner layers, hyperreflective foci, pigment epithelium atrophy, as well as the form of edema (diffuse, cystic) and ellipsoid zone disorder. Intravitreal injections of dexamethasone implant (“Ozurdex”) were used as drug therapy of PMO.The results showed that OCT morphostructural changes such as neuroepithelial detachment were significantly more frequent in patients with PMO diagnosed before 9 months, while hyperreflective foci, disorganization of the inner retinal layers, and ellipsoid zone disorder were more frequent in the comparison group. At the same time, there was no statistically significant difference in the macular and parafoveal edema height, frequency of edema form and presence of such a sign as pigment epithelium atrophy in both groups. Evaluation of the efficacy of intravitreal injection of “Ozurdex” implant in both groups showed that after 1–2 months from the beginning of treatment in the group with early detection of PMO complete regression was obtained in all patients, while in the second studied group complete regression occurred only in one third of patients. The regression of PMO was accompanied by improvement of BCVA in the first group from 0.4 to 0.7, in the second group — from 0.3 to 0.6. Out of 28 patients, 3 patients required re-injection of the implant in average 11 months after the first injection.Conclusion. The OCT biomarkers of PMO should be considered in treatment planning and subsequent dynamic follow-up. Early diagnosis of PMO, as well as the use of intravitreal dexamethasone implant (“Ozurdex”) determines high efficiency of treatment and maximum visual rehabilitation of patients.


  • Post-radiation macular edema after brachytherapy for choroidal melanoma (Ru/Rh106): risk factors and correction possibilities

    by A.A. Bykhovsky, I.E. Panova, E.V. Samkovich

    ЦЕЛЬ ИССЛЕДОВАНИЯ Улучшение непосредственных результатов брахитерапии меланомы хориоидеи за счет выявления факторов риска развития постлучевого макулярного отека. МАТЕРИАЛ И МЕТОДЫ Исследование включало 63 пациента (63 глаза), которым по поводу меланомы хориоидеи (МХ) была выполнена брахитерапия Ru/Rh106, средняя суммарная очаговая доза (СОД) на вершину составляла 123,95±8,1 Гр, средняя СОД на склеру — 760,88±503,81 Гр. Градация по системе TNM: T1 — 18 пациентов, T2 — 18, T3 — 27. Средняя проминенция опухоли 4,37±2,21 мм, средняя ширина основания 11,07±2,93 мм. Проанализировано 9 факторов риска развития постлучевого макулярного отека. Срок наблюдения от 12 до 48 мес. РЕЗУЛЬТАТЫ И ОБСУЖДЕНИЕ Установлено, что постлучевой макулярный отек встречался в 41% случаев. Медикаментозная терапия постлучевого макулярного отека у 11 пациентов начиналась с периокулярного введения глюкокортикостероидов (ГКС) пролонгированного действия. В 4 случаях данная терапия привела к полному регрессу постлучевого макулярного отека. 7 пациентам потребовалось дополнительное интравитреальное введение импланта ГКС пролонгированного действия, что привело к полному регрессу макулярного отека у 6 пациентов. У 12 пациентов была выявлена вторичная неоваскуляризация в макулярной и парамакулярной зонах на основании данных оптическая когерентная томография в режиме ангиографии. В связи с этим им были выполнены интравитреальные инъекции ингибиторов ангиогенеза. У 7 пациентов лечение привело к полному регрессу постлучевого макулярного отека, у 5 — к частичному. ЗАКЛЮЧЕНИЕ К достоверным факторам риска развития данного осложнения можно отнести постэкваториальное расположение МХ и выраженные лучевые реакции раннего послеоперационного периода. Медикаментозная терапия постлучевого макулярного отека возможна с применением ГКС пролонгированного действия и интравитреальных инъекций ингибиторов ангиогенеза.


  • Open Access

    Brachytherapy in organ-preserving treatment of choroidal melanoma: complications and the possibility of their prediction

    by A. A. Bykhovsky, I. E. Panova, E. V. Samkovich

    This review analyzed the domestic and foreign literature on brachytherapy of choroidal melanoma using ruthenium ophthalmic applicators. The review highlights the historical aspects of radiation treatment, from the first experience of using ionizing radiation in the treatment of malignant neoplasms to modern methods of brachytherapy; presents the radiobiological foundations of radiation therapy; considers the issues of radiation pathomorphosis, reflecting the nature of pathological changes in the choroidal melanoma tissue during brachytherapy; shows the dependence of the effect of exposure ionizing radiation from the phase of the cycle of cell division; and also describes the presence of changes characteristic of the response to ionizing radiation in unirradiated tissues. The analysis of various post-radiation complications, both early and late, was carried out in some detail, with emphasis on the possibility of predicting and preventing them in real clinical practice. A comparison is made in terms of the frequency of development of various post-radiation complications in the works of domestic and foreign authors, as well as a comparison with the effect of ionizing radiation from other radioactive isotopes. Recommendations of experts are given regarding the correct calculation of the dose to the sclera and medication support, based on many years of experience in the use of ruthenium ophthalmic applicators for brachytherapy of choroidal melanoma. The risks of developing such late complications as radiation maculopathy and radiation neuropathy have been demonstrated, especially in pre-equatorial tumor localization. The possibilities of modern methods of instrumental diagnostics for studying the processes occurring in the area of the tumor, as well as changes in the surrounding tissues, are shown, which determines the feasibility and importance of further study of this issue.